PLYMOUTH MEETING, PA — Harmony Biosciences Holdings Inc. (Nasdaq: HRMY) will participate in the 2026 Cantor Global Healthcare Conference in New York on Sept. 10, putting the Plymouth Meeting pharmaceutical company before investors focused on the healthcare sector.
Harmony’s management team is scheduled to participate in a fireside chat at 10:20 a.m. ET, the company reported.
A webcast of the presentation will be available through the investor relations section of Harmony’s website at https://ir.harmonybiosciences.com/.
Harmony Biosciences develops and commercializes therapies for patients with rare neurological diseases and unmet medical needs. The company was established by Paragon Biosciences LLC in 2017 and is headquartered in Plymouth Meeting.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.